Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study-Reference-Cited by-同舟云学术

Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study

Published:2022-08 Issue:33 Volume:40 Page:4780-4787
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Pichon Sylvie,Moureau Annick,Petit Celine,Chu L.,Essink B.,Muse D.,Saleh J.,Guinet-Morlot Françoise,Minutello Ada-Maria

Funder

Sanofi Pasteur SA

Sanofi

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference30 articles.

1. Estimating the Global Burden of Endemic Canine Rabies;Hampson;PLoS NeglTrop Dis,2015

2. World Health Organization, Rabies vaccines: WHO position paper, April 2018 - Recommendations. Weekly epidemiological record, 2018. 93(16): p. 201-220.

3. World Health Organization, WHO fact sheet: Rabies. 17 May 2021. Available at https://www.who.int/news-room/fact-sheets/detail/rabies. Accessed 23 Septl 2021. 2021.

4. Human Rabies: a 2016 Update;Jackson;Curr Infect Dis Rep,2016

5. Rabies: a medical perspective;Jackson;Rev Sci Tech,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10–60 year-old demographic;Vaccine;2024-10

2. Immunogenicity and Safety of a Purified Vero Rabies Vaccine—Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial;Clinical Infectious Diseases;2024-03-13

3. Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults;Vaccine;2023-12

4. Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults;Human Vaccines & Immunotherapeutics;2023-11-03

5. A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures;Vaccines;2023-08-01